Vertex lays off 125 staffers, slims Rhode Island campus after ditching failed diabetes cell-device combo
The company is merging its three buildings at its Providence, Rhode Island campus into one and leaving behind 125 staffers after a recent phase 1/2 fail prompted Vertex to end work on its "cells plus device" diabetes prospect.
The company is merging its three buildings at its Providence, Rhode Island campus into one and leaving behind 125 staffers after a recent phase 1/2 fail prompted Vertex to end work on its "cells plus device" diabetes prospect.
